Valueact Capital Cuts Stake in Dresser-Rand Group Inc. (DRC) To 2.6% From 6.6%

Valueact Capital, led by Jeffrey Ubben, has reduced its position in Dresser-Rand Group Inc. (NYSE:DRC). The fund has revealed, in a newly amended filing with the Securities and Exchange Commission, that it holds around 2 million shares of the company, representing 2.6% of the company’s common stock. According to the filing, the fund has sold around 3.0 million shares in multiple transactions. Previously, Valueact Capital reported a 6.6% stake in the company, containing around 5 million common shares.

VALUEACT CAPITAL

Dresser-Rand Group Inc. (NYSE:DRC) is a supplier of rotating equipment solutions to the worldwide oil, gas, petrochemical, and process industries. With a market cap of $4.90 billion, the company operates manufacturing facilities in the United States, France, United Kingdom, Spain, Germany, Norway, India, and Brazil.

For the first quarter of 2014, the company reported net income of $16.6 million, or $0.22 per diluted share, for the first quarter, compared to net income of $32.9 million, or $0.43 per diluted share for the first quarter 2013. In a press release, the company said that its net income and EPS for the first quarter were reduced by about $10.8 million and $0.14, respectively, as a result of the impact of the draft Spanish regulation. Dresser-Rand Group Inc. (NYSE:DRC) posted revenues for the first quarter of $699.1 million, down from $766.4 million for the same quarter of 2013.

Siemens AG is reportedly planning to acquire Dresser-Rand Group Inc. (NYSE:DRC), Bidness Etc reported last week, citing German business publication Manager Magazin.

The largest shareholders of the company, aside from Valueact Capital, include Iridian Asset Management, managed by David Cohen and Harold Levy, and Adage Capital Management, run by Phill Gross and Robert Atchinson, holding 4.88 million shares, and 1.34 million shares, respectively.

Shares of Dresser-Rand Group Inc. (NYSE:DRC) traded down by 4.20% to $64.07 on Wednesday. For the company’s stock, analysts have the consensus average target price of $62.38, and the consensus average recommendation is ‘Hold.’

Disclosure: none

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!